Medtronic plc
MDT Stock News
Latest MDT news
Here's Why Medtronic (MDT) Fell More Than Broader Market
Zacks Investment Research · Wed, 23 Sep 2026 18:51:04 -0400
Medtronic (MDT) reached $89.3 at the closing of the latest trading day, reflecting a -1.62% change compared to its last close.
Medtronic: Buy The 3% Yield And Strong Free Cash Flow Growth
Seeking Alpha · Wed, 23 Sep 2026 15:54:06 -0400
Medtronic is initiated with a buy rating and a $106.33 price target, implying 17% upside and a 3% dividend yield. Q1 FY27 results exceeded expectations, with normalized revenue growth of 7% and notable strength in Cardiovascular and Neuroscience segments. Guidance was raised for revenue and EPS, but margin expansion is expected to materialize gradually as product mix shifts toward higher-margin recurring revenues.
Medtronic: The Turnaround Is No Longer Quiet
Seeking Alpha · Wed, 23 Sep 2026 08:24:08 -0400
Medtronic delivered solid Q1 FY27 results, with organic revenue growth of ~7%, and raised full-year guidance to 7.25–7.75%. Newer businesses, especially Cardiac Ablation Solutions, are now meaningful contributors, supporting a more robust growth profile for MDT. The MiniMed separation will make MDT smaller but more profitable, with expected margin improvements and a sharper focus on core segments.
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga · Wed, 23 Sep 2026 07:05:06 -0400
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Jim Cramer Called Medtronic a "Quandary." Here's Why He's Exactly Right.
The Motley Fool · Tue, 22 Sep 2026 14:15:00 -0400
Over time, Medtronic's business got bloated, and growth slowed. The medical device giant overhauled its business and is starting to see stronger results.
Medtronic: Don't Miss Out On This Dividend Aristocrat Deal Now
Seeking Alpha · Tue, 22 Sep 2026 10:14:08 -0400
Medtronic has trounced the S&P 500 index in recent months. The company's strong showing in Q1 2027 prompted it to raise its non-GAAP EPS guidance for FY 2027. Medtronic's interest coverage ratio and net debt to EBITDA ratio are both healthy.
3 Dividend Stocks to Buy and Hold for 10 Years
The Motley Fool · Fri, 18 Sep 2026 18:13:01 -0400
Pfizer has a deep pipeline that could help improve its approved lineup and financial results over the medium term. Abbott Laboratories' core medical device business remains strong, and the company has attractive opportunities elsewhere.
Market information is provided for research and visualization and is not investment advice.